BioGaia AB Ownership
BIOG-B Stock | SEK 115.60 1.30 1.11% |
BioGaia |
BioGaia Stock Ownership Analysis
About 50.0% of the company shares are held by institutions such as insurance companies. The book value of BioGaia AB was currently reported as 19.53. The company has Price/Earnings To Growth (PEG) ratio of 1.9. BioGaia AB last dividend was issued on the 9th of May 2022. The entity had 5:1 split on the 18th of May 2022. BioGaia AB develops, markets, and sells probiotic products with documented health benefits worldwide. BioGaia AB was founded in 1990 and is headquartered in Stockholm, Sweden. BioGaia AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 144 people. For more info on BioGaia AB please contact Isabelle Ducellier at 46 8 55 52 93 00 or go to https://www.biogaia.com.BioGaia AB Outstanding Bonds
BioGaia AB issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioGaia AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioGaia bonds can be classified according to their maturity, which is the date when BioGaia AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
MGM Resorts International Corp BondUS552953CD18 | View |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BioGaia Stock
BioGaia AB financial ratios help investors to determine whether BioGaia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioGaia with respect to the benefits of owning BioGaia AB security.